Search and content
Articles, newsletters, and video that get your company found and cited.
Isovertic is the growth agency for healthcare, pharma, biotech, medical devices, and life sciences tools and diagnostics. We publish the articles, newsletters, social posts, and video that put your company in front of the buyer already looking for what you sell. Founders, CEOs, presidents, VPs of commercial, VPs of marketing, chief scientific officers, chief medical officers, medical directors, principal investigators, practice administrators, and directors of billing hire us when their website has to earn a serious reader's trust before a salesperson ever joins the conversation.
Ground State includes one published article, one newsletter, eight social posts, and a monthly report, with the website rebuild included. Excitation doubles social to 16 posts. Amplification adds a YouTube channel. Pricing is published.
What this actually is
A steady, published rhythm of articles a scientist or clinician can find, cite, and forward. Not a blog that fills an empty navigation item. Not a content library that reads like it was written for a general audience by someone who has never sat in a clinical or scientific meeting.
A principal investigator comparing an assay wants a clear write-up of how yours performs. A practice administrator trying to price a service change wants a plain explanation of what actually happens in the office. A chief medical officer preparing for a committee wants evidence before the room votes. If your site has the answer in language they recognize, you have a real advantage before your salesperson makes the first call.
The writing is built for the scientist or clinician, not a general audience. We work from your evidence, your approved claims, your product knowledge, your clinical or scientific review process, and the objections your salespeople hear on real calls. If the answer needs a caveat, it gets one. If your medical, legal, and regulatory reviewer needs to see it first, we set up that path.
The deliverables, by name
- Articles on your site, written from your source material and reviewed for accuracy.
- A newsletter sent to your list, with the article, the reason it matters, and a real next step.
- Social posts across the channels you actually use, pointing back to the article and to the offer.
- A YouTube channel at Amplification and above, with research, script, production, and publishing handled by our team.
- A short monthly report listing what was published, how it performed, and what is scheduled next.
- Sales enablement material your team can send after a call, before a committee review, or when a prospect asks for proof.
Why publishing matters for this kind of sale
Healthcare, pharma, biotech, medical device, and life sciences tools and diagnostics buyers do diligence before they take a meeting. Google's own guidance says search visibility takes four months to a year to move, per Google Search Central. Sales cycles in these categories are often long enough that a contract signed this year may have started with a search many months earlier. That gap is where a real publishing program earns its money. You cannot cold-call your way through it, and a paid ad without a page worth reading after the click is a fast way to spend a budget with nothing to show.
Every piece we publish also makes the rest of the program stronger. A Google Ads landing page needs a real article to link to. An outbound message needs a useful follow-up link. A salesperson needs a credible written answer when a buyer asks for evidence. The website turns into a working library your company owns, rather than a set of claims that vanish when a campaign ends.
Which package includes publishing
Ground State, $3,000 per month. One published article, one newsletter, eight social posts a month, one monthly report, and the $15,000 website rebuild and hosting spread across the 12-month engagement. The right first step for a company that needs to appear regularly before it adds paid advertising or outbound.
Excitation, $5,000 per month plus ad spend. Doubles social to 16 posts a month, adds a managed Google Ads campaign, a landing page, automated inbound follow-up within 30 seconds, and a monthly strategy call.
Amplification, $10,000 per month plus ad spend. Higher-volume articles and social, a YouTube channel, weekly account review, one dedicated person calling and emailing your prospects with meetings verified against the meeting quality standard, and the option to add the HIPAA form-and-call stack at $750 per month or the MLR review gate at $500 to $1,200 per month.
Quantum Leap, from $25,000 per month plus ad spend. The publishing program run on one brand or several, in-house video and photography, two dedicated people calling and emailing your prospects, media buying across streaming and broadcast, and a quarterly operations audit.
Every package is a 12-month engagement. Every package includes the website rebuild and hosting. See the full breakdown on the pricing page.
The honest limit
Published work compounds slowly. You may see the first signs that pieces are being found around month three. The effect usually gets clearer from month six. If you need meetings sooner, pair publishing with a Google Ads campaign or a dedicated person calling and emailing your prospects. We will not tell a founder that one article repairs a quarter. It does not.
This moves fastest when your buyers already search in specific language: a gene, a regulation, a billing code, a device model, a clinical protocol. If your category is so new that nobody is looking for it yet, publishing alone cannot put a meeting on the calendar. The program has to lead with calls, emails, and LinkedIn to reach the people who should own what you sell, while the published work builds the recognition that makes those conversations easier. We will tell you that before you sign.
What we don't do
We are not a volume writing vendor, a general promotion shop, or a studio that ships clever posts without knowing what happens after the click. We do not publish clinical or scientific claims your reviewer has not seen. We do not hand your team a topic spreadsheet and ask them to turn it into work. We plan, write, review, publish, and report.
Written by content writers on staff and reviewed by a subject-matter expert when the content is technical. Life-science work follows terminology controls a molecular biologist on staff wrote, before it reaches a client's medical, legal, and regulatory reviewer.
What founders ask first
You may see the first signs around month three. The effect usually gets clearer from month six. If you need meetings sooner, pair publishing with Google Ads.
We use AI in research and production tooling. Every published page is planned, edited, and fact-checked by a person, and reads like it.
We earn links with original, useful pages rather than buying them.
Send us your best-converting landing page and one article you are proud of.
If you would rather talk it through, book a pipeline call and send us your best-converting landing page and one article you are proud of. In about ten minutes we will tell you whether the article is doing useful work, what your site is missing, and whether the right next move is publishing, paid ads, or a rebuild. Sometimes the honest answer is you are already fine, and we are happy to say so and hand you back your afternoon.
George Stoff, Founder and Lead Engineer
Full-stack engineer with more than 30 years building the systems companies sell through. He built the method Isovertic runs on and stays on every account as the standards owner and the escalation path. When search algorithms shift or a compliance question comes up, you get his engineering judgment. Day-to-day execution runs on the team he trained.
LinkedInKristen Coughlin, Chief Operating Officer
Trained molecular biologist. Ten years selling translational research products, then institutional operations at the Yale School of Medicine. She documented George's method, trained the team on it, and built the operation so the same system runs the same way on every account.
LinkedIn